Selvedge Venture invests in Pre-Seed, Seed and Series A companies focused on alleviating age-related medical conditions, specifically Metabolic Syndrome, Cancer, and Neurodegenerative Diseases, leveraging biotechnology and digital technologies. It targets founders and startups using biotechnology, machine learning tools, and integrated data assets.